114 related articles for article (PubMed ID: 19707223)
41. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
Giovannucci E; Chen J; Smith-Warner SA; Rimm EB; Fuchs CS; Palomeque C; Willett WC; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):970-9. PubMed ID: 14578131
[TBL] [Abstract][Full Text] [Related]
42. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil.
de Cássia Carvalho Barbosa R; da Costa DM; Cordeiro DE; Vieira AP; Rabenhorst SH
Anticancer Res; 2012 Nov; 32(11):4805-11. PubMed ID: 23155246
[TBL] [Abstract][Full Text] [Related]
43. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study.
Chen J; Kyte C; Valcin M; Chan W; Wetmur JG; Selhub J; Hunter DJ; Ma J
Int J Cancer; 2004 Jul; 110(4):617-20. PubMed ID: 15122597
[TBL] [Abstract][Full Text] [Related]
44. Variants in folate pathway genes as modulators of genetic instability and lung cancer risk.
Piskac-Collier AL; Monroy C; Lopez MS; Cortes A; Etzel CJ; Greisinger AJ; Spitz MR; El-Zein RA
Genes Chromosomes Cancer; 2011 Jan; 50(1):1-12. PubMed ID: 20842733
[TBL] [Abstract][Full Text] [Related]
45. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis.
Langsenlehner T; Renner W; Yazdani-Biuki B; Langsenlehner U
Breast Cancer Res Treat; 2008 Feb; 107(3):459-60. PubMed ID: 17453338
[TBL] [Abstract][Full Text] [Related]
46. Risk of congenital heart defects is influenced by genetic variation in folate metabolism.
Christensen KE; Zada YF; Rohlicek CV; Andelfinger GU; Michaud JL; Bigras JL; Richter A; Dubé MP; Rozen R
Cardiol Young; 2013 Feb; 23(1):89-98. PubMed ID: 22475273
[TBL] [Abstract][Full Text] [Related]
47. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
48. Lack of catalytic activity of a murine mRNA cytoplasmic serine hydroxymethyltransferase splice variant: evidence against alternative splicing as a regulatory mechanism.
Liu X; Szebenyi DM; Anguera MC; Thiel DJ; Stover PJ
Biochemistry; 2001 Apr; 40(16):4932-9. PubMed ID: 11305908
[TBL] [Abstract][Full Text] [Related]
49. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
[TBL] [Abstract][Full Text] [Related]
50. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
51. Serum folate, total homocysteine levels and methylenetetrahydrofolate reductase 677C>T polymorphism in young healthy female Japanese.
Taguchi T; Mori H; Hamada A; Yamori Y; Mori M
Asia Pac J Clin Nutr; 2012; 21(2):291-5. PubMed ID: 22507617
[TBL] [Abstract][Full Text] [Related]
52. Lack of association between methylenetetrahydrofolate reductase genetic polymorphisms and postmenopausal breast cancer risk.
Ziva Cerne J; Stegel V; Gersak K; Novakovic S
Mol Med Rep; 2011; 4(1):175-9. PubMed ID: 21461582
[TBL] [Abstract][Full Text] [Related]
53. Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population.
Lu Q; Jiang K; Li Q; Ji YJ; Chen WL; Xue XH
Tumour Biol; 2015 May; 36(5):3757-62. PubMed ID: 25566964
[TBL] [Abstract][Full Text] [Related]
54. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
55. Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene.
Beilby J; Ingram D; Hähnel R; Rossi E
Eur J Cancer; 2004 May; 40(8):1250-4. PubMed ID: 15110890
[TBL] [Abstract][Full Text] [Related]
56. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
57. Association between MTHFR gene 1298A>C polymorphism and breast cancer susceptibility: a meta-analysis based on 38 case-control studies with 40,985 subjects.
Zhang J; Zhang L; Li G
World J Surg Oncol; 2016 Aug; 14(1):230. PubMed ID: 27568010
[TBL] [Abstract][Full Text] [Related]
58. Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a candidate-gene association study in a South-eastern European population.
Papandreou CN; Doxani C; Zdoukopoulos N; Vlachostergios PJ; Hatzidaki E; Bakalos G; Ziogas DC; Koufakis T; Zintzaras E
DNA Cell Biol; 2012 Feb; 31(2):193-8. PubMed ID: 21875371
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR)single nucleotide polymorphisms.
Alshatwi AA
Food Chem Toxicol; 2010 Jul; 48(7):1881-5. PubMed ID: 20417243
[TBL] [Abstract][Full Text] [Related]
60. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: a Sardinian preliminary case-control study.
Castiglia P; Sanna V; Azara A; De Miglio MR; Murgia L; Pira G; Sanges F; Fancellu A; Carru C; Bisail M; Muroni MR
Int J Med Sci; 2019; 16(8):1089-1095. PubMed ID: 31523170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
